Streetbeat News

Regulatory

BTCUSD

ETHUSD

SPY

Two Democratic U.S. Senators have requested the Justice Department to investigate whether Binance made false statements to Congress, according to a Reuters report.

Portfolio Pulse from Happy Mohamed

June 08, 2023 | 12:06 pm

OCEA

Ocean Biomedical has been granted a patent for its malaria vaccine in Brazil, potentially expanding its market and revenue opportunities.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 12:02 pm

ACON

Aclarion announced that their Nociscan cost-effectiveness abstract was presented at the ISASS Annual Meeting, showing that Nociscan statistically dominates provocative discography (PD) in terms of cost and effectiveness. The study was performed at CDMI through an NSF grant sponsored by Aclarion.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:37 am

FXI

MSFT

SPY

A bipartisan group of US senators plans to introduce a bill aimed at boosting the country's AI capabilities to keep up with China. The bill will focus on research, development, and deployment of AI technologies.

Portfolio Pulse from Charles Gross

June 08, 2023 | 11:23 am

GME

OXM

QQQ

SMR

SPY

Stock futures were mixed on Thursday as traders await the Federal Reserve's rate-setting meeting next week. Bond yields rose, reflecting expectations of rate hikes. The eurozone fell into a technical recession, potentially aggravating fears of a recession in the US. LPL Financial's Jeffrey Buchbinder has a muted outlook for the market, stating that the risk-reward for stocks is no longer compelling.

Portfolio Pulse from Shanthi Rexaline

June 08, 2023 | 11:11 am

CD

Chindata Group has announced the formation of a special committee to evaluate and consider the non-binding proposal received on June 6.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:04 am

CING

Cingulate has completed its Phase 3 adult dose-optimization trial for CTX-1301, a treatment for Attention Deficit/Hyperactivity Disorder (ADHD). Results are expected in 3Q 2023, with pivotal Phase 3 trials in pediatric/adolescent patients scheduled for initiation in the same quarter.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:04 am

LIAN

LianBio has completed enrollment in its pivotal Phase 3 LIBRA trial of TP-03 for Chinese patients with Demodex blepharitis. The trial aims to evaluate the safety and efficacy of TP-03 in treating the condition.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:02 am

BCDA

BioCardia has been granted a patent in Japan for its Helix biotherapeutic delivery system, which is designed to improve the delivery of cell and gene therapies. The patent expands the company's intellectual property portfolio and may open up new market opportunities.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:01 am

RCKT

Rocket Pharmaceuticals has received FDA Fast Track and Orphan Drug Designations for its RP-A601 gene therapy for PKP2 Arrhythmogenic Cardiomyopathy. This will expedite the development and review process for the therapy.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:01 am